QNL: Medium-Term Adjunctive Predictive Cardiovascular Indicator
FDA product code QNL. Class II, classified under 21 CFR 870.2210. What the classification flags say about Part 820 under the QMSR.
As of Nov 2, 2026, FDA product code QNL (Medium-Term Adjunctive Predictive Cardiovascular Indicator) is Class II under 21 CFR 870.2210, reviewed through 510(k), with 6 linked 510(k), De Novo or BK numbers, 0 PMAs and 0 recall product records.
Classification
- Product code
- QNL
- Device name
- Medium-Term Adjunctive Predictive Cardiovascular Indicator
- Device class
- Class II
- Regulation
- 21 CFR 870.2210
- Review panel
- Cardiovascular
- Premarket route
- 510(k)
- CGMP-exempt flag
- No
- Life-sustaining flag
- No
- Implant flag
- No
- Third-party review
- Not a candidate
- Summary malfunction reporting
- Ineligible
FDA definition. The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Data from openFDA as of 2 November 2026. Read the record on openFDA · FDA product code classification database
Part 820 requirements the flags point to
Part 820 rules for QNL
- CGMP exemptionClassification regulation, 21 CFR parts 862 to 892
- Not flaggedFDA does not flag this product code as exempt.A manufacturer of a finished device of this type falls under part 820 (21 CFR 820.1(a)). Some classification regulations exempt only part of a generic device type, so read the regulation for your device.FDA: QMSR, CGMP exemptions · 21 CFR 820.35
- Design and development, ISO 13485 clause 7.321 CFR 820.10(c)
- Rule names this classRule names Class II.21 CFR 820.10(c) requires manufacturers of class II and class III devices to comply with clause 7.3 and its subclauses.21 CFR 820.10
- Traceability, ISO 13485 clause 7.5.9.221 CFR 820.10(d)
- Not flaggedFDA does not flag this code as life-supporting or life-sustaining.820.10(d) is not indicated by this flag.21 CFR 820.10 · 21 CFR 860.3 · QMSR final rule, comment 49
- Complaint and record content21 CFR 820.35
- Rule names this classApplies to every finished-device manufacturer, exempt or not.820.35 adds content to complaint records, servicing records and UDI recording on top of ISO 13485 clause 4.2.5. FDA says CGMP exemption does not lift these records.21 CFR 820.35 · FDA: QMSR, CGMP exemptions
These flags describe the classification of a product code. They are not a determination for a specific device or manufacturer. How a manufacturer meets 21 CFR 820.10 depends on its own device, its intended use and the full text of the rule.
Clearances and recalls on record
- 510(k), De Novo and BK numbers linked
- 6 · Search these clearances
- PMA numbers linked
- 0
- Recall product records
- 0
- Adverse event reports
- Search MAUDE for QNL
Recall records count products, and one recall event can add many. Counts show activity in a category. They do not measure its safety.
Newest QNL clearances
- Deterioration Index Version 2: Epic Systems Corporation, Sep 18, 2026
- eCARTv5 Clinical Deterioration Suite (“eCART”): Agilemd, Inc., Jun 21, 2024
- CLEWICU System: Clew Medical , Ltd., Jan 13, 2024
- SignalHF (IM008): Implicity, Inc., Oct 25, 2023
- Global Hypoperfusion Index (GHI) Algorithm: Edwards Lifesciences, LLC, Jul 26, 2023
- CLEWICU System (ClewICUServer and ClewICUnitor): Clew Medical , Ltd., Jan 9, 2021
Search all 7,098 product codes, or read the guide to the Part 820 rules behind these flags.
Check your quality documents against Part 820
Arca puts your SOPs and design files in a library and compares them against the Part 820 requirements for your device in a grid, one row per document and one column per requirement, with each cell cited to its source.